Mon, Nov 30, 12:20 PM, Zacks
Cardinal Health: Strong Buy on Strong Q1, Positive Outlook
On Nov 28, Zacks Investment Research raised Cardinal Health Inc. (CAH) to a Zacks Rank 1 (Strong Buy).
Mon, Nov 23, 11:00 AM, Zacks
Cardinal Health Unveils Positive Data for INCRAFT Stent Graft
Cordis, a Cardinal Health, Inc. (CAH) company, recently announced positive four-year data from its INNOVATION Trial at the 2015 VEITHsymposium held in New York City.